亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。
Discovery of Novel Inhibitors of the FKBP51 Protein from a High-throughput Drug Screen
技术优势
First treatment to target FKBP51, All FDA approved compounds, Can be immediately implemented
详细技术说明
Through the use of high-throughput screening University of South Florida researchers have identified several compounds with strong inhibitory activity against FKBP51, which could potentially be immediately implemented into clinics to treat specific patient populations with high levels of FKBP51. These drugs are all FDA approved and could be prescribed off label for the purpose of reducing FKBP51 levels. Patients with elevated levels of FKBP51, specifically those with SNPs in the FKBP5 gene or aged/AD patients, could immediately benefit from receiving drugs that target inhibition of FKBP51.
国家/地区
美国
欲了解更多信息，请点击 这里
